France is experiencing a critical shortage of dermatologists, with average appointment wait times reaching three months and extending to several years in some regions, according to reports from Paris Select Book and France 3 Régions. To maintain melanoma detection rates, the Société Française de Dermatologie (SFD) has validated alternative screening pathways, including pharmacist triage and specialized centers.
- Average Wait Times: Three months on average, though some patients wait years for an appointment.
- Critical Zones: Puy-de-Dôme and Clermont-Ferrand are among the hardest-hit areas.
- Validated Alternatives: The SFD supports the use of pharmacies and dedicated screening centers to accelerate diagnosis.
How long are the wait times for skin screenings?
The gap between patient needs and specialist availability varies significantly by region. While Paris Select Book reports an average wait time of three months, the reality in other parts of the country is more severe. According to France 3 Régions, some patients find that securing a dermatologist appointment now takes years.
“Today, finding a dermatologist is measured in years.”
Where are the most severe shortages located?
The distribution of specialists is uneven across France. According to La Montagne, the Puy-de-Dôme department and the city of Clermont-Ferrand are currently on the “front line” of this shortage, facing acute difficulties in providing timely dermatological care to the population.
What alternatives does the SFD recommend for lesion screening?
To prevent delays in diagnosing skin cancers, the Société Française de Dermatologie (SFD) has validated alternative methods for initial screenings. According to Paris Select Book, these alternatives are designed to “change the game” by creating faster routes to diagnosis for high-risk patients.
One primary solution involves the integration of community pharmacies. According to La Montagne, pharmacies are increasingly serving as the first point of contact where patients can show suspicious skin lesions. This allows for a more rapid initial assessment and a streamlined referral process to specialists when a lesion appears concerning.
How are new screening centers addressing the gap?
In addition to pharmacy triage, some regions are establishing dedicated infrastructure to bypass traditional appointment bottlenecks. La Voix du Nord reports the opening of a skin cancer screening center in the Lille metropolis. Officials associated with the center indicated that such facilities are intended to scale, stating that “tomorrow, there will be [centers] everywhere” to ensure patients do not have to wait for standard clinic openings to receive a screening.
